SLNSW-Real-world efficacy and safety of nivolumab in pr...-TN_cdi_doaj_primary_oai_doaj_org_article_8dc2e19ba5544857a0d837544b55b59a

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

Full title: Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

Author/creator: Verzoni, Elena, Cartenì, Giacomo, Cortesi, Enrico, Giannarelli, Diana, De Giglio, Andrea, Sabbatini, Roberto, Buti, Sebastiano, Rossetti, Sabrina, Cognetti, Francesco, Rastelli, Francesca, Sobrero, Alberto, Turci, Daniele, Sternberg, Cora N, Porta, Camillo, Cappuzzo, Federico, Tortora, Giampaolo, Tassinari, Davide, Panni, Stefano, Pazzola, Antonio, Surico, Gianmarco, Raimondi, Alessandra, De Giorgi, Ugo, Procopio, Giuseppe, Italian Nivolumab Renal Cell Cancer Early Access Program group, on behalf of the Italian Nivolumab Renal Cell Cancer Early Access Program group.

Call Numbers:

Record Identifier: TN_cdi_doaj_primary_oai_doaj_org_article_8dc2e19ba5544857a0d837544b55b59a

Language: English

Formats: Articles

Publishers: England: BioMed Central Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8dc2e19ba5544857a0d837544b55b59a

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

    Record identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_8dc2e19ba5544857a0d837544b55b59a

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8dc2e19ba5544857a0d837544b55b59a

    Share

    Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8dc2e19ba5544857a0d837544b55b59a

    Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

    Full title

    Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

    Author / Creator

    Verzoni, Elena ; Cartenì, Giacomo ; Cortesi, Enrico ; Giannarelli, Diana ; De Giglio, Andrea ; Sabbatini, Roberto ; Buti, Sebastiano ; Rossetti, Sabrina ; Cognetti, Francesco ; Rastelli, Francesca ; Sobrero, Alberto ; Turci, Daniele ; Sternberg, Cora N ; Porta, Camillo ; Cappuzzo, Federico ; Tortora, Giampaolo ; Tassinari, Davide ; Panni, Stefano ; Pazzola, Antonio ; Surico, Gianmarco ; Raimondi, Alessandra ; De Giorgi, Ugo ; Procopio, Giuseppe ; Italian Nivolumab Renal Cell Cancer Early Access Program group ; on behalf of the Italian Nivolumab Renal Cell Cancer Early Access Program group

    Publisher

    England: BioMed Central Ltd

    Journal title

    Journal for immunotherapy of cancer, 2019, Vol.7 (1), p.99-99

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_8dc2e19ba5544857a0d837544b55b59a

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adverse events Analysis Cancer cells Cancer therapies Carcinoma, Renal cell Clinical trials Creatinine Diarrhea Disease Drug dosages Drug therapy Expanded access trials Hepatitis Immunotherapy Inflammatory bowel disease Kidney cancer Lung cancer Melanoma Metastasis Monoclonal antibodies Patients Population Pruritus Renal cell carcinoma Steroids Systematic review Targeted cancer therapy Thyroid gland Vitiligo

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_8dc2e19ba5544857a0d837544b55b59a

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8dc2e19ba5544857a0d837544b55b59a

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections